Skip to content

Erasca, Inc. ERAS Market capitalization

Market capitalization at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$123.83B-0.2%
Eli Lilly logo
Eli LillyLLY
$821.68B+10.8%
Pfizer logo
PfizerPFE
$159.73B+11.1%
Amgen logo
AmgenAMGN
$189.67B+13.3%
Revolution Medicines, Inc. logo
Revolution Medicines, Inc.RVMD
$19.27B+193%
Tango Therapeutics logo
Tango TherapeuticsTNGX
$2.99B+1,915%

Other financials

Income statement

See full
Operating income-$187.9M-427%
Net income-$183.4M-492%
EPS (diluted)-$0.60-445%

Balance sheet

See full
Cash & equivalents$47.3M-33.0%
Total debt$46.0M-9.6%
Total equity$393.5M-1.5%
Total assets$461.2M-2.1%

Cash flow

See full
Operating cash flow-$27.4M+13.2%
CapEx$36.0K-56.6%
Free cash flow-$27.4M+13.3%

Valuation

See full
Enterprise value$4.25B+1,265%

Returns & leverage

See full
Return on equity-69.9%+77.1pp
Debt / equity0.1×0.0×
Current ratio9.5×-2.8×

Where this comes from

Computed from the period-end share price: $5.03B.

The official record: Erasca, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Erasca, Inc.'s market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Erasca, Inc.'s market capitalization?
Erasca, Inc. (ERAS) reported market capitalization of $5.03B in Q1 2026.
How has Erasca, Inc.'s market capitalization changed year-over-year?
Erasca, Inc.'s market capitalization increased by 1195.8% year-over-year, from $388.07M to $5.03B.
What is the long-term trend for Erasca, Inc.'s market capitalization?
Over 4 years (2021 to 2025), Erasca, Inc.'s market capitalization has grown at a -22.5% compound annual growth rate (CAGR), from $2.93B to $1.06B.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.